Blue Water Navy Vietnam Veterans and Agent Orange Exposure
Committee on Blue Water Navy Vietnam Veterans and Agent Orange Exposure, Board on the Health of Select Populations, Institute of Medicine
E-bok
2011503 kr
AvCommittee on Blue Water Navy Vietnam Veterans and Agent Orange Exposure,Board on the Health of Select Populations
535 kr
Läs direkt i Bokus Reader – eller ladda ned till din enhet
Over 3 million U.S. military personnel were sent to Southeast Asia to fight in the Vietnam War. Since the end of the Vietnam War, veterans have reported numerous health effects. Herbicides used in Vietnam, in particular Agent Orange have been associated with a variety of cancers and other long term health problems from Parkinson''s disease and type 2 diabetes to heart disease. Prior to 1997 laws safeguarded all service men and women deployed to Vietnam including members of the Blue Navy. Since then, the Department of Veteran Affairs (VA) has established that Vietnam veterans are automatically eligible for disability benefits should they develop any disease associated with Agent Orange exposure, however, veterans who served on deep sea vessels in Vietnam are not included. These "Blue Water Navy" veterans must prove they were exposed to Agent Orange before they can claim benefits. At the request of the VA, the Institute of Medicine (IOM) examined whether Blue Water Navy veterans had similar exposures to Agent Orange as other Vietnam veterans.
Blue Water Navy Vietnam Veterans and Agent Orange Exposure comprehensively examines whether Vietnam veterans in the Blue Water Navy experienced exposures to herbicides and their contaminants by reviewing historical reports, relevant legislation, key personnel insights, and chemical analysis to resolve current debate on this issue.
Committee on Blue Water Navy Vietnam Veterans and Agent Orange Exposure, Board on the Health of Select Populations, Institute of Medicine
503 kr
Volume 10: Update of Health Effects of Serving in the Gulf War Committee on Gulf War and Health, Board on the Health of Select Populations, Institute of Medicine, and Medicine National Academies of Sciences, Engineering, Deborah Cory-Slechta, Roberta Wedge
952 kr
Committee on the Management of the Air Force Health Study Data and Specimens--Report to Congress, Board on the Health of Select Populations, Institute of Medicine
570 kr
Committee on Shipboard Hazard and Defense II (SHAD II), Board on the Health of Select Populations, Institute of Medicine, and Medicine National Academies of Sciences, Engineering
691 kr
Committee on the Assessment of Ongoing Efforts in the Treatment of Posttraumatic Stress Disorder, Board on the Health of Select Populations, Institute of Medicine
794 kr
Committee on the Assessment of Resiliency and Prevention Programs for Mental and Behavioral Health in Service Members and Their Families, Board on the Health of Select Populations, Institute of Medicine, Laura Aiuppa Denning, Marc Meisnere, Kenneth E. Warner
812 kr
Committee on Social Security Cardiovascular Disability Criteria, Board on the Health of Select Populations, Institute of Medicine
950 kr
Committee on the Evaluation of the Supplemental Security Income (SSI) Disability Program for Children with Speech Disorders and Language Disorders, Board on the Health of Select Populations, and Families Board on Children, Youth, Institute of Medicine, Division of Behavioral and Social Sciences and Education, and Medicine National Academies of Sciences, Engineering, Sara Rosenbaum, Patti Simon
1 059 kr
and Their Families Committee on the Initial Assessment of Readjustment Needs of Military Personnel, Veterans, Board on the Health of Select Populations, Institute of Medicine
579 kr
Committee on Social Security Cardiovascular Disability Criteria, Board on the Health of Select Populations, Institute of Medicine
829 kr